These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4743717)

  • 21. Species differences in the alteration of drug-metabolizing activities of liver microsomes by thyroxine treatment.
    Kato R; Takanaka A; Takahashi A; Onoda K
    Jpn J Pharmacol; 1969 Mar; 19(1):5-18. PubMed ID: 4389560
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of microsomal drug metabolism by methylenedioxybenzenes.
    Anders MW
    Biochem Pharmacol; 1968 Nov; 17(11):2367-70. PubMed ID: 5718145
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of a pituitary mammotropic tumor on hepatic microsomal drug metabolism in the rat.
    Wilson JT
    Biochem Pharmacol; 1968 Jul; 17(7):1449-57. PubMed ID: 5690694
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of age, sex and drug treatment on microsomal drug metabolism in four rat strains.
    Furner RL; Gram TE; Stitzel RE
    Biochem Pharmacol; 1969 Jul; 18(7):1635-41. PubMed ID: 5806106
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship of dietary essential fatty acid consumption to hepatic drug hydroxylation.
    Wade AE; Wu B; Caster WO
    Pharmacology; 1972; 7(5):305-14. PubMed ID: 4644001
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of malathion on hepatic microsomal metabolism of the male mouse.
    Stevens JT
    Pharmacology; 1974; 11(6):330-5. PubMed ID: 4413070
    [No Abstract]   [Full Text] [Related]  

  • 27. Further studies on the metabolism of drugs by subfractions of hepatic microsomes.
    Gram TE; Rogers LA; Fouts JR
    J Pharmacol Exp Ther; 1967 Mar; 155(3):479-93. PubMed ID: 6022622
    [No Abstract]   [Full Text] [Related]  

  • 28. Relation of the gonadal hormones to growth hormone actions on hepatic drug metabolism in rats.
    Kramer RE; Greiner JW; Rumbaugh RC; Sweeney TD; Colby HD
    J Pharmacol Exp Ther; 1978 Feb; 204(2):247-54. PubMed ID: 621663
    [No Abstract]   [Full Text] [Related]  

  • 29. Divergence of growth hormone actions on hepatic drug metabolism in the presence and absence of the pituitary gland.
    Kramer RE; Greiner JW; Colby HD
    Life Sci; 1975 Sep; 17(5):779-86. PubMed ID: 1207398
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):37-50. PubMed ID: 4153090
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth and lactogenic hormone stimulation of ornithine decarboxylase in neonatal rat brain.
    Roger LJ; Schanberg SM; Fellows RE
    Endocrinology; 1974 Sep; 95(3):904-11. PubMed ID: 4408225
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of manganese on the hepatic microsomal mixed function oxidase enzyme system in the rat.
    Deimling MJ; Schnell RC
    Fundam Appl Toxicol; 1984 Dec; 4(6):1009-18. PubMed ID: 6519370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between type I and type II substrate binding to cytochrome P-450 by variation of temperature.
    Misselwitz R; Jänig GR; Rein H; Buder E; Zirwer D; Ruckpaul K
    Acta Biol Med Ger; 1976; 35(5):K 19-25. PubMed ID: 983603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species differences in the effect of morphine administration or adrenalectomy on the substrate interactions with cytochrome P-450 and drug oxidations by liver microsomes.
    Kato R; Onoda KI; Takanaka A
    Biochem Pharmacol; 1971 Jun; 20(6):1093-9. PubMed ID: 5118111
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of cytochrome P-450-dependent aminopyrine N-demethylase in rat brain: comparison with hepatic aminopyrine N-demethylation.
    Marietta MP; Vesell ES; Hartman RD; Weisz J; Dvorchik BH
    J Pharmacol Exp Ther; 1979 Feb; 208(2):271-9. PubMed ID: 33263
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism of drugs in old rats. I. Activities of NADPH-linked electron transport and drug-metabolizing enzyme systems in liver microsomes of old rats.
    Kato R; Takanaka A
    Jpn J Pharmacol; 1968 Dec; 18(4):381-8. PubMed ID: 4388257
    [No Abstract]   [Full Text] [Related]  

  • 37. Dietary fatty acid-induced alterations of hepatic microsomal drug metabolism.
    Norred WP; Wade AE
    Biochem Pharmacol; 1972 Nov; 21(21):2887-97. PubMed ID: 4646808
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of the normal postnatal increase in drug-metabolizing enzyme activity in rat liver by a pituitary tumor.
    Wilson JT
    Pediatr Res; 1968 Nov; 2(6):514-8. PubMed ID: 4302513
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions of the hexobarbital enantiomers with rat liver microsomes.
    Feller DR; Lubawy WC
    Pharmacology; 1973; 9(3):129-37. PubMed ID: 4714228
    [No Abstract]   [Full Text] [Related]  

  • 40. The nature of the reverse type I (modified type II) spectral change in liver microsomes.
    Schenkman JB; Cinti DL; Orrenius S; Moldeus P; Kraschnitz R
    Biochemistry; 1972 Nov; 11(23):4243-51. PubMed ID: 5079897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.